Immunotherapy is the treatment of disease by inducing, enhancing or suppressing an immune response. T-cell activation and inactivation requires the coordination of a multitude of co-inhibitory and co-stimulatory signals and most immunotherapies modulate these signals.

Therapeutic manipulation of immunopathways has led to encouraging clinical results for the treatment of a number of diseases, including cancer, autoimmune disorders, and inflammatory diseases. Research in this field is rapidly growing as investigators seek to identify the next generation of therapies. 

BPS Bioscience’s portfolio of immunotherapy-related products is continually expanding. Current products include high purity proteins, including unique biotinylated versions, antibodies, assay kits, and screening services.

For more information on BPS's product, or on the particular Antibodies, Assay Kits or Soluble Receptors available, please contact us locally at